Cumberland Pharmaceuticals (CPIX) Return on Equity: 2009-2025
Historic Return on Equity for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Sep 2025 value amounting to -0.12%.
- Cumberland Pharmaceuticals' Return on Equity rose 30.00% to -0.12% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.12%, marking a year-over-year increase of 30.00%. This contributed to the annual value of -0.25% for FY2024, which is 5.00% down from last year.
- Latest data reveals that Cumberland Pharmaceuticals reported Return on Equity of -0.12% as of Q3 2025, which was down 19.43% from -0.10% recorded in Q2 2025.
- Cumberland Pharmaceuticals' Return on Equity's 5-year high stood at 0.06% during Q1 2021, with a 5-year trough of -0.42% in Q3 2024.
- For the 3-year period, Cumberland Pharmaceuticals' Return on Equity averaged around -0.20%, with its median value being -0.13% (2025).
- In the last 5 years, Cumberland Pharmaceuticals' Return on Equity crashed by 36bps in 2024 and then climbed by 30bps in 2025.
- Quarterly analysis of 5 years shows Cumberland Pharmaceuticals' Return on Equity stood at 0.04% in 2021, then decreased by 20bps to -0.15% in 2022, then decreased by 4bps to -0.19% in 2023, then decreased by 8bps to -0.27% in 2024, then rose by 30bps to -0.12% in 2025.
- Its Return on Equity was -0.12% in Q3 2025, compared to -0.10% in Q2 2025 and -0.13% in Q1 2025.